India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

The Managing Director/CEO, Neimeth International Pharmaceuticals, Valentine Okelu, at a media parley in Lagos disclosed that ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

AstraZeneca unveiled both its fourth-quarter and full-year 2024 results before market open today, revealing that its total revenue was $14.89 billion. This represented a meaty 24% improvement over Q4 ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

Industry associations react to President Trump’s tariffs and what they could mean for the pharmaceutical supply chain.